Company intelligence / Profile preview
Cellogen Therapeutics
New Delhi, Delhi, India
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
Cellogen Therapeutics is an Indian biotechnology company dedicated to developing affordable and accessible cell and gene therapies for cancer and genetic blood disorders. Founded by Dr. Gaurav Kharya, the company focuses on next-generation CAR-T cell therapies, including bi-specific constructs targeting CD19 and CD20, and CRISPR-based gene editing for hemoglobinopathies like Thalassemia and Sickle Cell Disease. Cellogen aims to significantly reduce the cost of these advanced treatments, making them viable for patients in emerging markets. The company has established strategic partnerships with leading Indian research institutions and secured investment from NATCO Pharma to advance its pipeline into clinical trials. Their approach combines innovative genetic engineering with cost-effective manufacturing to address high unmet medical needs.
- Therapeutic areas
- OncologyHematology
- Modalities
- CAR-T cell therapyGene therapyCRISPR-based therapyCell therapyStem cell therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
NATCO PharmaCSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB)Regional Centre for Biotechnology (DBT-RCB)CSIR-Indian Institute of Chemical Biology (CSIR-IICB)Christian Medical College (CMC) Vellore
Beyond the preview
Go deeper on Cellogen Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellogen Therapeutics.